PHP

Parkman Healthcare Partners Portfolio holdings

AUM $911M
1-Year Est. Return 51.9%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+51.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$911M
AUM Growth
+$46.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
103
New
Increased
Reduced
Closed

Top Buys

1
+$18.2M
2
+$14.8M
3
+$12.9M
4
MCK icon
McKesson
MCK
+$8.56M
5
FOLD icon
Amicus Therapeutics
FOLD
+$8.5M

Top Sells

1
+$19.2M
2
+$18.7M
3
+$17.8M
4
RVTY icon
Revvity
RVTY
+$15.2M
5
IQV icon
IQVIA
IQV
+$15.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX icon
76
Dynavax Technologies
DVAX
$1.76B
$2.69M 0.28%
271,306
+1,175
TVRD
77
Tvardi Therapeutics
TVRD
$40.7M
$2.53M 0.26%
+65,000
SLDB icon
78
Solid Biosciences
SLDB
$503M
$2.45M 0.26%
+396,396
DAWN icon
79
Day One Biopharmaceuticals
DAWN
$1.24B
$2.13M 0.22%
301,746
-198,254
RARE icon
80
Ultragenyx Pharmaceutical
RARE
$2.35B
$2.06M 0.22%
68,636
-79,344
FDMT icon
81
4D Molecular Therapeutics
FDMT
$455M
$1.74M 0.18%
+200,000
QTRX icon
82
Quanterix
QTRX
$323M
$1.37M 0.14%
252,211
-263,781
ANNX icon
83
Annexon
ANNX
$993M
$1.24M 0.13%
405,953
+1,759
BFLY icon
84
Butterfly Network
BFLY
$1.12B
$1.16M 0.12%
+602,192
MASS icon
85
908 Devices
MASS
$240M
$879K 0.09%
100,368
+368
LUNG icon
86
Pulmonx
LUNG
$73.8M
$811K 0.08%
500,662
-104,367
CMPS
87
Compass Pathways
CMPS
$663M
$573K 0.06%
+100,000
ENTX icon
88
Entera Bio
ENTX
$70.2M
$539K 0.06%
280,822
-75,000
EDAP
89
EDAP TMS
EDAP
$153M
$355K 0.04%
154,832
OVID icon
90
Ovid Therapeutics
OVID
$124M
$264K 0.03%
+202,978
MRUS
91
DELISTED
Merus
MRUS
– –
-162,980
NRIX icon
92
Nurix Therapeutics
NRIX
$1.9B
– –
-228,271
ALKS icon
93
Alkermes
ALKS
$5.47B
– –
0
ANIP icon
94
ANI Pharmaceuticals
ANIP
$1.83B
– –
-128,478
ARDX icon
95
Ardelyx
ARDX
$1.9B
– –
-301,086
DGX icon
96
Quest Diagnostics
DGX
$20.3B
– –
-40,997
GILD icon
97
Gilead Sciences
GILD
$171B
– –
-131,675
QQQ icon
98
Invesco QQQ Trust
QQQ
$410B
– –
0
REPL icon
99
Replimune Group
REPL
$593M
– –
-896,710
RVTY icon
100
Revvity
RVTY
$13B
– –
-157,196
1 2 3
4
5